Pathways of plasma cell differentiation in autoimmunity
自身免疫中浆细胞分化的途径
基本信息
- 批准号:8605829
- 负责人:
- 金额:$ 47.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-08 至 2017-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAffectAntibodiesAntibody FormationAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-LymphocytesBindingBone MarrowCell CountCell SurvivalCellsCellular biologyCongenic MiceDataDevelopmentFamilyGenerationsGoalsHomeostasisImmuneImmune responseKnockout MiceLifeLongevityLymphoidLymphoid TissueMaintenanceMature BoneMediatingModelingMolecularMusNew ZealandOrganPathway interactionsPhysiologicalPlasma CellsProductionPropertyProteinsRecombinantsRegulationReportingRoleSignal TransductionSourceStagingT-LymphocyteTALL-1 proteinTestingThinkingTimeTissuesTransgenic MiceTumor Necrosis Factor Receptorautoreactive B cellbis(3-bis(4-chlorophenyl)methyl-4-dimethylaminophenyl)aminecell typedesigneffective therapymembermouse modelplasma cell differentiationprogenitorreceptorresearch studyself-renewal
项目摘要
DESCRIPTION (provided by applicant): Pathways of plasma cell differentiation in autoimmunity. The overall goal of this project is to directly assess the role of BCMA in the regulation of plasma cell (PC) survival and the development of autoantibodies. BCMA is a member of the TNF receptor family and was first described by our group as a critical receptor on PCs that, upon binding its ligands BAFF and APRIL, mediates their long-term survival in the bone marrow (BM). This has led to our hypothesis that BCMA has an intrinsic effect on PC longevity by directly delivering pro-survival signals to mature BM PCs that serve as a long-term source for antibody production. However, signaling through BCMA could also affect earlier B cell intermediates that give rise to BM PCs and, thus, contribute indirectly to the development and persistence of antibody- producing PCs in the BM. We have previously demonstrated that the development of a reservoir of BM PCs could be achieved in a T cell-dependent immune response through the generation of a unique BM resident cell type, the PC progenitor (PCpre), with the capacity for both long-term self renewal and terminal differentiation to long-lived PCs in
the BM1-3. New data provided in this application demonstrates that the ability of PCpre to give rise to long-lived BM PCs is dependent on BAFF/APRIL. We further hypothesize that the capacity to sustain long-lived PCs is achieved in part at the PCpre stage, specifically through BCMA signaling in PCpre, which controls both their maintenance in the BM and their differentiation to long-lived PCs. Thus, BCMA signaling is required for the establishment and stability of a normal repertoire of specific, protective antibodies. In the absence of this mechanism, we predicted that the normal functions of PC-derived stable antibody production in immune homeostasis would be disrupted. In support of this hypothesis, we recently reported that, in both the lpr and New Zealand-derived autoimmune-prone mouse models, BCMA deficiency causes dramatic B cell lymphoproliferation, accumulation of PCpre and long-lived PCs in secondary lymphoid organs, enhanced autoantibody production, increased numbers of BAFF-producing cells, and early lethality compared to BCMA- sufficient autoimmune-prone mice4. These observations suggest that, in autoimmune-prone mice, signals through BCMA on B cells help control B cell homeostasis and the stringent elimination of autoreactive B cells. In this proposal, we will use a combination of transgenic, congenic, and knockout mice to characterize BCMA signaling at sequential stages of the PC differentiation pathway. This strategy will allow us to determine the physiologic role of BCMA in PC biology as well as intrinsic alterations in B cells, exogenous signals from innate immune cells, and T cell help in controlling abnormal development and survival of long-lived PCs in autoimmune-prone mice.
描述(由申请人提供):自身免疫中浆细胞分化的途径。该项目的总体目标是直接评估 BCMA 在调节浆细胞 (PC) 存活和自身抗体发展中的作用。 BCMA 是 TNF 受体家族的一员,我们的团队首先将其描述为 PC 上的关键受体,在结合其配体 BAFF 和 APRIL 后,介导 PC 在骨髓 (BM) 中的长期存活。这导致我们假设 BCMA 通过直接向成熟的 BM PC 传递促生存信号而对 PC 寿命产生内在影响,而 BM PC 作为抗体生产的长期来源。然而,通过 BCMA 的信号传导也可能影响产生 BM PC 的早期 B 细胞中间体,从而间接促进 BM 中产生抗体的 PC 的发育和持续存在。我们之前已经证明,通过生成独特的 BM 驻留细胞类型 PC 祖细胞 (PCpre),可以在 T 细胞依赖性免疫反应中实现 BM PC 库的开发,该细胞具有长期自我更新和终端分化,以实现长寿命 PC
BM1-3。本申请中提供的新数据表明,PCpre 产生长寿命 BM PC 的能力取决于 BAFF/APRIL。我们进一步假设维持长寿命 PC 的能力部分是在 PCpre 阶段实现的,特别是通过 PCpre 中的 BCMA 信号传导,该信号控制它们在 BM 中的维护以及它们向长寿命 PC 的分化。因此,BCMA 信号传导是特异性保护性抗体正常库的建立和稳定性所必需的。如果没有这种机制,我们预测PC衍生的稳定抗体产生在免疫稳态中的正常功能将被破坏。为了支持这一假设,我们最近报道称,在 lpr 和新西兰衍生的自身免疫倾向小鼠模型中,BCMA 缺乏会导致 B 细胞淋巴细胞急剧增殖、PCpre 和长寿命 PC 在次级淋巴器官中积累、自身抗体产生增强,与 BCMA 充足的自身免疫倾向小鼠相比,产生 BAFF 的细胞数量增加,以及早期致死率4。这些观察结果表明,在易患自身免疫的小鼠中,B 细胞上通过 BCMA 发出的信号有助于控制 B 细胞稳态并严格消除自身反应性 B 细胞。在本提案中,我们将使用转基因、同类和基因敲除小鼠的组合来表征 PC 分化途径的连续阶段的 BCMA 信号传导。这一策略将使我们能够确定 BCMA 在 PC 生物学中的生理作用,以及 B 细胞的内在改变、先天免疫细胞的外源信号和 T 细胞有助于控制自身免疫倾向中长寿命 PC 的异常发育和存活。老鼠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loren D Erickson其他文献
Loren D Erickson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loren D Erickson', 18)}}的其他基金
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
IgE 抗体对小鼠和人类动脉粥样硬化中寡糖半乳糖-α-1,3-半乳糖 (α-gal) 的反应
- 批准号:
10649670 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
Tracking Extracellular Vesicles Derived From B Cells in Autoimmunity
追踪自身免疫中 B 细胞衍生的细胞外囊泡
- 批准号:
10450549 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
Tracking Extracellular Vesicles Derived From B Cells in Autoimmunity
追踪自身免疫中 B 细胞衍生的细胞外囊泡
- 批准号:
10549373 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
IgE 抗体对小鼠和人类动脉粥样硬化中寡糖半乳糖-α-1,3-半乳糖 (α-gal) 的反应
- 批准号:
10818690 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
IgE 抗体对小鼠和人类动脉粥样硬化中寡糖半乳糖-α-1,3-半乳糖 (α-gal) 的反应
- 批准号:
10851057 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
IgE 抗体对小鼠和人类动脉粥样硬化中寡糖半乳糖-α-1,3-半乳糖 (α-gal) 的反应
- 批准号:
10536408 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis
IgE 抗体对小鼠和人类动脉粥样硬化中寡糖半乳糖-α-1,3-半乳糖 (α-gal) 的反应
- 批准号:
10842540 - 财政年份:2022
- 资助金额:
$ 47.11万 - 项目类别:
High-dimensional profiling of B cells in food allergy
食物过敏中 B 细胞的高维分析
- 批准号:
9121279 - 财政年份:2016
- 资助金额:
$ 47.11万 - 项目类别:
Pathways of plasma cell differentiation in autoimmunity
自身免疫中浆细胞分化的途径
- 批准号:
8699294 - 财政年份:2012
- 资助金额:
$ 47.11万 - 项目类别:
相似国自然基金
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
P29单克隆抗体的3-羟基丁酰化修饰对其稳定性影响及提升抗泡型包虫病作用的研究
- 批准号:82360402
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
肠道菌群影响PD-1抗体对潜伏HIV的作用及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
心衰患者中单克隆β1-肾上腺素受体自身抗体的筛选及其对受体构象影响的研究
- 批准号:32271156
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
SARS-CoV-2 S2蛋白与肠道菌群交叉反应抗体的产生机制及其对新冠肺炎病程和疫苗效果的影响
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 47.11万 - 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 47.11万 - 项目类别:
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
滤泡调节性 T 细胞作为癌症免疫治疗新细胞靶点的评估
- 批准号:
10737557 - 财政年份:2023
- 资助金额:
$ 47.11万 - 项目类别:
Tyk2 and Associated Cytokines in Salivary Gland Autoimmunity
Tyk2 和唾液腺自身免疫中的相关细胞因子
- 批准号:
10733367 - 财政年份:2023
- 资助金额:
$ 47.11万 - 项目类别:
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Crohn's disease
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗克罗恩病
- 批准号:
10820782 - 财政年份:2023
- 资助金额:
$ 47.11万 - 项目类别: